Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile

Journal of Infection

Volumn 35, Issue 2, 1997, Pages 171-176

  Maass, M ^a   Gieffers, J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIAL VIRULENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE;

EID: 0030707937     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)91743-6     Document Type: Article

References (28)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. C. pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-461.
2. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995; 103: 769-796.
3. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart study. Ann Intern Med 1992; 116: 273-278.
4. Linnanmäki E, Leinonen M, Mattila K et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-1134.
5. Campbell LA, O'Brien ER, Cappuccio AL et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-588.
6. Maass M, Krause E, Engel PM, Krüger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997: 4: 48: 699-706.
7. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with C. pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
8. Mendall MA, Carrington D, Strachan D et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121-128.
9. Maass M, Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infect Dis 1996; 6: 65-70.
10. Maass M, Dalhoff K. Isolierung von Chlamydia pneumoniae bei atypischer Pneumonie. Dtsch Med Woschrft 1994; 119: 1462-1466.
11. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995; 103: 141-148.
12. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31: 1161-1176.
13. Giesecke J. Modern infectious disease epidemiology. London: Edward Arnold, 1994.
14. Kuo CC, Chen HH, Wang SP, Grayston JT. Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol 1986; 24: 1034-1037.
15. Ladany S, Black CM, Farshy CE, Ossewaarde JM, Barnes RC. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol 1989; 27: 2778-2783.
16. Iijima Y, Miyashita N, Kishimoto T, Kanamoto Y, Soejima R, Matsumoto A. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans. J Clin Microbiol 1994; 32: 583-588.
17. Freidank HM, Herr AS, Jacobs E. Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots. Eur J Clin Microbiol Infect Dis 1993; 12: 947-951.
18. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary artery fatty streaks and flbrolipid plaques. J Clin Microbiol 1993; 31: 2212-2214.
19. Kanamoto Y, Iijima Y, Miyashita N, Matsumoto A, Sakano T. Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan. Microbiol Immunol 1993; 37: 495-498.
20. Campbell LA, Kuo CC, Wang SP, Grayston JT. Serological response to Chlamydia pneumoniae infection. J Clin Microbiol 1990; 28: 1261-1264.
21. Campbell LA, Kuo CC, Grayston JT. Structural and antigenic analysis of Chlamydia pneumoniae, Infect Immun 1990; 58: 93-97.
22. Gaydos CA, Quinn TC, Bobo LD, Eiden JJ. Similarity of the Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun 1992; 60: 5319-5323.
23. Perez Melgosa M, Kuo CC, Campbell LA. Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol Lett 1993; 112: 199-204.
24. Perez Melgosa M, Kuo CC, Campbell LA. Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope. Infect Immun 1994; 62: 880-886.
25. Kornak JM, Kuo CC, Campbell LA. Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog. Infect Immun 1991; 59: 721-725.
26. Raulston JE, Davis CH, Schmiel DH, Morgan MW, Wyrick PB. Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp 70 family of proteins. J Biol Chem 1993; 268: 23139-23147.
27. 7 Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57 kD protein. J Exp Med 1989; 169: 663-675.
28. Grayston JT, Kuo CC, Campbell LA, Benditt EP. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993; 14 (Suppl. K): 66-71.